Dr. Haig Kazazian is a professor of pediatrics and molecular biology and genetics at the Johns Hopkins University School of Medicine.
A pioneering geneticist at Johns Hopkins, Dr. Kazazian was named as one of the first plaintiffs in the Supreme Court’s 2013 ruling that companies cannot patent parts of naturally occurring human genes.
Dr. Kazazian's lab focuses on the biology of LINE-1 (L1) retrotransposons in human beings and mice. They are also working on a second important project to carry out gene therapy of hemophilia A using AAV vectors. Recent research in the Kazazian lab has found actively “jumping genes” in humans, yielding new evidence that the genome contains numerous pesky mobile elements that may help to explain why people have such a variety of physical traits and disease risks.